Edition:
United States

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

129.30USD
8 Dec 2016
Change (% chg)

$0.65 (+0.51%)
Prev Close
$128.65
Open
$128.18
Day's High
$130.52
Day's Low
$127.24
Volume
644,413
Avg. Vol
602,072
52-wk High
$136.46
52-wk Low
$92.42

Select another date:

Mon, Dec 5 2016

Photo

U.S. attorneys argue Aetna-Humana deal violates antitrust law

WASHINGTON A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks.

Novartis CEO plays down prospects for Actelion bid: Blick

VIENNA Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction.

Actelion shares plunge on report it eyes 'complicated' J&J deal

ZURICH Shares in Swiss biotech company Actelion plunged on Tuesday after a report the company was not actively considering selling itself, but instead weighing a "complicated deal" to link with U.S. healthcare giant Johnson & Johnson .

Actelion shares plunge on report it eyes "complicated" J&J deal

ZURICH, Nov 29 Shares in Swiss biotech company Actelion plunged on Tuesday after a report the company was not actively considering selling itself, but instead weighing a "complicated deal" to link with U.S. healthcare giant Johnson & Johnson.

J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg

Nov 24 U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter.

BRIEF-Aetna entered into a first amendment to term loan credit agreement

* On November 21, company entered into a first amendment to term loan credit agreement dated as of July 30, 2015- SEC filing

Aetna CEO expects some ACA benefits to stay: Dealbook conference

NEW YORK Aetna Inc Chief Executive Officer Mark Bertolini said he expected some benefits of President Barack Obama's national healthcare reform law will stick under President-elect Donald Trump, like allowing young adults to stay on their family's health insurance.

Aetna CEO expects some ACA benefits to stay-Dealbook conference

NEW YORK, Nov 10 Aetna Inc Chief Executive Officer Mark Bertolini said he expected some benefits of President Barack Obama's national healthcare reform law will stick under President-elect Donald Trump, like allowing young adults to stay on their family's health insurance.

BRIEF-Aetna and Banner Health announces a new JV health plan in Arizona

* Aetna and Banner Health launch a new joint venture health plan in Arizona

BRIEF-Aetna adds Sarepta's DMD drug Exondys 51 to its precertification list

* Aetna adds Sarepta's DMD drug Exondys 51 to its precertification list, effective nov 15 Source text for Eikon: http://aet.na/2eR7liT Further company coverage:

Select another date: